Rationale and design of the Renal Lifecycle trial assessing the effect of dapagliflozin on cardiorenal outcomes in severe chronic kidney diseaseW Bakker, J W Rood, Ron T. Gansevoort et al.|Nephrology Dialysis Transplantation|2025Cited by 18